Andere Sprachen Evome Medical Technologies Inc.

Aktien

A3E27P

CA30053H1055

BRTL

Markt geschlossen - Toronto S.E. Andere Börsenplätze 20:34:40 21.06.2024			% 5 Tage	% 1. Jan.
0,09 ^CAD	-10,00 %		-14,29 %	-57,14 %

04.06.	Transcript : Evome Medical Technologies Inc., Q2 2024 Sales/ Trading Statement Call, Jun 04, 2024
31.05.	Evome Medical Technologies Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Evome Medical Technologies Announces Securities Issuances	14.06.
Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2	03.06.
Evome Medical Technologies : TECHNOLGIES, INC - Form 6-K	03.06.
Evome Medical Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	31.05.
Evome Medical Technologies Provides Biodex Operations Update	30.05.
Evome Medical Technologies Inc. Receives an Initial Purchase Order from VMS	30.05.
Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt	30.05.
Evome Medical Technologies : FOREIGN PRIVATE ISSUER STATUS - Form 6-K	23.04.
Evome Medical Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16.04.
Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled	12.04.
Canadian Investment Regulatory Organization Trade Resumption - EVMT	02.04.
Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt	02.04.
Riddell, Inc. acquired Simbex, LLC from Evome Medical Technologies Inc. for $3.6 million.	02.04.
Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023	01.04.
Evome Medical Engages ICP Securities Inc. for Automated Market Making Services	27.02.
Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman	15.02.
Evome Medical Technologies Inc. Announces Board Changes	15.02.
Evome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by 2% for 2024	08.02.
Evome Medical Technologies Inc. Announces CFO Changes	02.02.
Evome Medical Technologies Inc. Announces Change of Principal Accounting Officer	02.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Evome Medical Technologies Inc.

Aktien

A3E27P

CA30053H1055

BRTL

Andere Sprachen

Filter